Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Novartis acquires Enablex

May 13, 2003

5-HT1A antagonists with utility in urinary tract disorders under study at Recordati

May 13, 2003

Licensing opportunity from Milkhaus: ML-04 for BPH and prostatitis

May 12, 2003

Cozaar approved for diabetics with kidney disease and high blood pressure in Canada

May 12, 2003

Patients associate clinical improvement with relative, not absolute, reduction in incontinence

May 9, 2003

New potential therapies described for postradical prostatectomy ED

May 9, 2003

New smooth muscle-selective muscarinic antagonists covered by Kyorin patent

May 8, 2003

U.S. approval for Cialis anticipated for second half of 2003

May 7, 2003

New data on the efficacy and safety of vardenafil in erectile dysfunction

May 7, 2003

The effects of Y-27632 in models of erectile dysfunction and overactive bladder

May 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...